Dom and John have had a busy summer, and due to recent pressing issues, episode #46 of “The Weekly Bioanlaysis” is an abbreviated version, focusing only on a review of recent news and resources within the industry. Our next episode #47 will focus on the recent announcement that Pfizer’s COVID vaccine has been officially approved by the FDA. Please come back and check that one out – and as always – please continue sending your thoughts, feedback and ideas for podcast episode topics!

"The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Twice every month, KCAS will bring you another 60 minutes (or so) of friendly banter between our two finest Senior Scientific Advisors as they chat over coffee and discuss what they've learned about the Bioanalytical world the past couple of weeks.

The Weekly Bioanalysis is brought to you by KCAS. KCAS is a progressive growing contract research organization of well over 150 talented and dedicated individuals committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the Pharmaceutical, Biopharmaceutical, Animal Health and Medical Device industries.